Skip to main content
. 2021 Jun 9;17(6):20200916. doi: 10.1098/rsbl.2020.0916

Table 1.

Heat stress survival characteristics during RNAi treatments. Differences compared to control were considered significant at p < 0.05 (*). p-value determination was realized with log-rank test and subsequent Bonferroni correction for the mean survival and Fisher's Exact test for specific time points. n = number of worms; min./med./max. = minimum/median/maximum; s.e.m. = standard error of the mean.

days until deaths of population reached
age at heat stress exposure RNAi treatment n 25% (min. survival) 50% (med. survival) 90% (max. survival) mean survival (days) s.e.m. change relative to control [%]
third day of adulthood EV 157 2.38 3.48 5.55 3.96 0.13
acox-1.1 151 1.90* 2.87* 5.17 3.49 0.13 −13.47
daf-22 152 1.93 3.21 4.86 3.52 0.12 −12.50
cat-4 152 1.43* 2.41* 4.65 3.05* 0.12 −29.84
pept-1 151 2.28 3.38 5.22 3.84 0.12 −3.13
EV 244 4.05 4.77 8.28 5.85 0.13
pig-1 249 3.43* 5.05 7.48* 5.47 0.12 −6.95
pak-2 240 4.26* 5.21* 8.57 6.24 0.13 +6.25
sad-1 243 3.85 4.69 7.59 5.59 0.12 −4.65
gsk-3 244 3.89 5.32* 8.46 6.15 0.13 +4.88
C25G6.3 241 3.74* 4.74 7.74 5.69 0.11 −2.81
seventh day of adulthood EV 158 1.81 2.73 4.34 3.23 0.09
acox-1.1 153 1.26* 1.88* 3.47* 2.51* 0.08 −28.69
daf-22 156 1.43* 2.13* 3.97 2.78* 0.09 −16.19
cat-4 158 1.35* 2.11* 3.95 2.80* 0.10 −15.36
pept-1 156 1.65 2.41* 3.98 3.03 0.09 −6.60
EV 228 2.60 4.05 6.67 4.61 0.12
pig-1 263 1.87* 2.90* 5.47* 3.61* 0.10 −27.70
pak-2 255 2.23 3.73 6.61 4.39 0.13 −5.01
sad-1 253 2.54 4.16 6.71 4.63 0.12 +0.43
gsk-3 246 1.77* 2.84* 6.22 3.84* 0.12 −20.05
C25G6.3 238 2.04* 3.16* 6.41 4.08 0.12 −12.99
twelfth day of adulthood EV 144 1.34 2.54 4.98 3.22 0.14
acox-1.1 150 1.22 2.31 4.48 2.93 0.12 −9.90
daf-22 154 0.40* 0.80* 2.60* 1.60* 0.08 −101.25
cat-4 157 0.93* 1.89 4.81 2.83 0.14 −13.78
pept-1 159 1.02* 1.93 4.95 2.91 0.14 −10.65
EV 193 1.63 2.65 5.89 3.50 0.13
pig-1 224 1.49* 2.30 4.17* 3.04* 0.08 −15.13
pak-2 178 1.16* 1.89* 4.42 2.75* 0.12 −27.27
sad-1 186 1.39 2.46 5.28 3.21 0.13 −9.03
gsk-3 155 0.41* 0.82* 2.32* 1.57* 0.07 −122.93
C25G6.3 169 1.39* 2.18* 4.39* 2.91* 0.11 −20.27